CS Paper Radar

Kernel-based External Validity of Experimental Studies

Federico Matteucci, Gerhard Neumann

cs.LG stat.MEstat.ML ·submitted 2026-10-09 14:08 UTC · v1
unusual

Abstract

The external validity of a study is the extent to which its findings generalize to unseen experimental conditions, such as datasets. We formalize the results of a study together with its research question, and define external validity as the probability that two independent and same-sized replications of the study produce results whose maximum mean discrepancy (MMD) is below a given tolerance. This approach, centered on the choice of a space of results and of an appropriate reproducing kernel for the MMD, is flexible enough to be deployed on multiple different types of results and research questions. Additionally, we establish an asymptotic power-law relation between the size of a study and the quantiles of the MMD, which we use to estimate the desired size of an externally valid study from a small-scale preliminary study. We deploy our framework to rankings with ties and discuss kernels suited to different research questions. Experiments on existing case studies and on a simulated newly designed study illustrate the applicability of the framework. We release our code as part of the genexpy Python module.

Closest papers

Nearest neighbours by meaning across the whole index.

Calibrating Reproduced Claims in Recommender Systems

cs.IR ·2026-09-22 ·Alan Said
published similarity 0.57
Abstract · Accepted to the Workshop Methodology First - Rethinking Research Assessment in RecSys (FRAME) September 28, 2026, Minneapolis, Minnesota, US…

Reproduction studies can produce mixed outcomes. Reported values may differ while the ordering of the compared methods remains the same, a result may hold only under some experimental conditions, or a released implementation may fail to reproduce a result that the model can still reach. The terms repeatability, reproducibility, and replicability describe how a follow-up study relates to the original experiment, but not which parts of the original claim are supported by the new results. We introduce \emph{claim calibration} as a way of stating the strongest claim supported by a follow-up study, together with the conditions under which it holds and the parts that remain untested. We apply this perspective to five original--follow-up paper pairs from recommender-systems research. The cases show that agreement in numerical values, method rankings, statistical results, and overall conclusions does not always coincide, and that follow-up studies often support only part of the original claim. Based on these observations, we propose a Claim Evidence Profile for reporting the original claim, its scope, the reproduction target, the reported results, the calibrated claim, and the parts of the original claim that remain unresolved.

0.37

Quantifying research uniqueness with Unbalanced Optimal Transport: Case studies of ten leading universities in neuroscience

cs.DL cs.SI ·2026-10-13 ·Yu Ota, Takayuki Ogi, Yo Nakawake, Daichi Mochihashi, Amane Koizumi
similarity 0.53
Abstract · 22 pages, 6 figures, 2 tables. Supplementary material included as an ancillary file

Research evaluation has developed around quantity, citation impact and, more recently, the accumulation of research excellence, but these dimensions remain largely dependent on citations, which describe how research is received rather than what it contains. We propose uniqueness as a complementary dimension and measure it with the Research Uniqueness Index (RUI), which asks how far a university's research sits from what is typical in its field, using no citations but the content of the research itself. Each researcher is represented by an embedding of their abstracts, and an unbalanced version of Optimal Transport returns the share of that work which cannot be matched into a random sample of same-field researchers, the standard population; that unmatched share is the score. Because every researcher is scored, a university is a distribution rather than one number, and we treat that distribution as the indicator: it shows whether uniqueness is spread across an institution or concentrated in a few groups. Quantiles summarise it and, being quantiles, do not reward size. Since uniqueness is defined only relative to a field, we demonstrate the index within one, neuroscience (Scopus, 2021-2025; 9,861 reference researchers). All ten universities studied sit well above the standard (RUI_median 0.40-0.53 versus 0.27) and five specialised institutes higher still (0.57-0.73), the most unique work often confined to a narrow niche that the same scores name. RUI is uncorrelated with citation impact, and a controlled test confirms that it tracks displacement from the field rather than topical concentration; results are robust to an alternative embedding and replicate in computer science and economics. The index is not intended as a league table: the gap above the standard and the researcher-level niche structure are stable, whereas the order among adjacent universities is not.

0.29

A Pitfall in the Evaluation of Gene Perturbation Models

cs.LG stat.AP ·2026-10-19 ·George Panagopoulos, Saman Omidi, Tsz Pan Tong, Jun Pang
benchmark similarity 0.53
Abstract

Gene perturbation models aim to predict transcriptional responses to unseen genetic interventions, but comparisons rely on heterogeneous evaluation metrics and differentially-expressed (DE) gene subsets. We investigate the consequences of these choices using eight methods across six single-gene perturbation datasets under a unified evaluation protocol. Varying the number of top DE genes reveals substantial instability in Precision-based rankings, with the winning method changing $86.7\%$ of the time, while rankings based on the rest of the metrics remain comparatively stable. Investigating this discrepancy exposes that repeating a single predicted expression profile across cell-level rows, a standard practice for many methods, can inflate significance estimates and produce excessively large predicted significant-DE sets. Specifically we found that $67.1\%$ of tested perturbation--gene pairs pass the significance threshold despite some of them having minuscule effects. We derive an inflation factor showing that replicated predictions can amplify the standardized Mann--Whitney statistic even after correction for tied ranks, without adding independent information. This artifact changes Precision mainly as the number of DE genes increases because for smaller cutoffs, most of the genes are already significant due to the effect-based ordering. Taking this pitfall into account in our benchmark comparison, we find that a random forest using Gene Ontology features achieves the best overall results.

0.18

Kurate: Scalable Scientific Quality Analysis

cs.CL ·2026-10-05 ·Matthew J. Vowels, Jamie Cummins
similarity 0.52
Abstract

Scientific search systems can find papers that are relevant to a question, but they generally do not assess the quality of the evidence that those papers provide. We present Kurate, a system that uses large language models (LLMs) to assess the quality of published studies. Kurate uses both the paper and its related documents (e.g., the study's trial registration and protocol), and links each of its judgments to the passage of text on which that judgment is based. We applied Kurate to a corpus of 4,347 papers (3,913 of which report randomized trials) and scored each paper on 8 dimensions of study design and reporting: specifically, statistical power, causal identification, preregistration, selective reporting, measurement validity, analysis prespecification, reporting transparency, and conflict of interest and funding. Across the corpus, we found that papers most often exhibited issues with statistical power, selective reporting, and analysis prespecification, although average quality differed between clinical areas. When compared against expert annotations of 60 held-out clinical-trial documents, the information Kurate extracted matched the expert label in 221/242 protocol scorepoints and 294/370 results-publication scorepoints, with AC1 0.94 and 0.81, respectively. Using a well-reputed, high quality clinical trial as a worked example, we show how a single paper's overall grade breaks down into separate judgments, with each linked to specific evidence from the trial's registration, protocol, and published report. Together, these results show that large-scale quality assessment of this kind is feasible, and that it can be used to address meta-scientific research questions.

0.31

Calibrated Evidence Inference With a Small, Permissively Licensed Open Model

cs.CL cs.LG ·2026-10-04 ·Johann Emmanuel Li
code/data similarity 0.52
Abstract · 22 pages, 2 figures, 15 tables. Code, results files and the paper's sources: https://github.com/johann-e-li/fiorillo. Model: https://doi.org…

Systematic reviewers who use a model to read randomized trials need each answer and a measure of how far to trust it. If the model is calibrated, so that its stated probabilities match how often it is right, a reviewer can accept its confident answers and check the rest by hand. This paper fine-tunes Qwen3-4B-Base with low-rank adapters and a classification head for evidence inference (Lehman et al., 2019; DeYoung et al., 2020): given a trial's article and a prompt that names an intervention, a comparator and an outcome, classify the result as a significant increase, a significant decrease or no significant difference. The articles of Evidence Inference 2.0 come from the open-access subset of PubMed Central, which includes articles under non-commercial and no-derivatives licenses, so the released model was fine-tuned only on the 1,431 of 2,657 training articles under CC BY, CC0 or the public domain; it is released under the Apache License 2.0 and runs on a laptop. On the test split, its expected calibration error is 0.017 and its log loss is lower than that of Gemma 4 31B-it given the same input zero-shot, meeting criteria registered on the Open Science Framework before testing. Its macro-F1, 0.925, is above every published result on that split that I found, though those systems used other inputs, scoring rules and prompt filters, and the test labels are public. Accepting its 80 percent most confident answers leaves an error rate of 2.6 percent among them. Context ablations show that the answers depend on the article, but the title alone carries some signal, which an informative title or recall of the trial could explain.

0.42

SCIRIGOR:Evaluating Open-Ended Scientific Analysis Beyond Final Scores

cs.AI ·2026-09-05 ·Bowen Liu, Shuo Nie, Bodong Du, Xiaomeng Li
benchmark similarity 0.52
Abstract

Scientific coding agents produce interdependent code, results, figures, and claims, yet evaluating final outputs alone does not establish whether their conclusions are scientifically supported. We formulate evidence-grounded multimodal scientific analysis, requiring agents to produce executable analyses and claims supported by results and visualizations from the same run. We introduce SciRIGOR, an evaluation framework and benchmark comprising 100 cases from scientific articles across six domains and 17 subfields. The framework reconstructs typed evidence graphs, separates artifact fidelity from relational validity, and scores complete claim-support paths while localizing the earliest unsupported relation. Source-grounded alternative paths accommodate scientifically equivalent analyses and visualizations. We evaluate 11 agent/model configurations. On full-benchmark runs, claims agree with faithful and unfaithful results at nearly identical rates (91.8% versus 91.0%). Yet no system exceeds 62.6% on the soft evidence-chain score or 18.0% strict whole-chain success. These findings show that internal coherence does not establish scientific correctness: evaluation must verify support along the complete data-to-claim path.

0.20

Scientific Discovery under Validation Congestion via Multi-Fidelity Pairwise Rankings

cs.LG ·2026-10-01 ·Kevin Tirta Wijaya, Alston Lo, Michael Sun, Wojciech Matusik, Vahid Babaei
similarity 0.51
Abstract

Modern computational methods can now propose candidate molecules, materials, and other scientific designs at an unprecedented scale, creating a validation congestion where candidates are abundant, but experimental capacity to physically evaluate them remains scarce. Discovering novel scientific designs has therefore become increasingly dependent on curation: selecting a small set of promising designs for slow and costly experiments. Existing curation methods typically rely on data-driven regression models that predict absolute scores, but training these models requires substantial experimental data to begin with. Yet, useful curation signals do not have to take the form of absolute measurements, as scientific design discovery is often comparative in nature. Here, we propose that curation can instead be primarily driven by expert pairwise rankings, which are substantially easier to gather. The expertise can come from computational tools or human input of multiple levels of fidelity, ranging from empirical rules of thumb to agentic workflows and experienced scientists. We introduce PRISMS, a framework that uses pairwise rankings from one or more experts, potentially spanning multiple levels of expertise, to identify the most promising candidates without relying on data-hungry regressors. When experts differ in fidelity and cost, PRISMS escalates pairwise queries from lower- to higher-fidelity rankers based on a Fisher-information criterion. In iterative screening that selects designs from fixed drug discovery libraries, PRISMS achieves 50% top-10 discovery recall in ~42% fewer rounds than regression-only active learning, and in ~15% fewer rounds than the ranking-based method with no selective escalation. In optimization that generates new designs without restriction to a predefined library, PRISMS achieves ~18.8% higher hypervolume than the Bayesian optimization baseline.

0.19

What Can a Leaderboard Certify? Compositional Controllability for Fair Evaluation and Training of Biomedical Literature-Review Agents

cs.LG cs.AIcs.CL ·2026-09-26 ·Zhaowei Han, Xiang Zhang, Lingxiao Guan, Danqi Hu, Kai Liu +2 more
benchmarkcode/data similarity 0.51
Abstract · 33 pages, 1 figure, 18 tables. Zhaowei Han, Xiang Zhang, and Lingxiao Guan contributed equally. Code: https://github.com/shawnzhg/LitReview-…

Leaderboards rank long-horizon agents by their final outputs. Yet a higher score alone does not establish whether two systems are comparable or which stage accounts for the difference. Unequal evidence, inputs, or budgets can affect scores, and statistical corrections do not remove this mismatch. We introduce compositional controllability to address these questions. A comparison window covers one stage, several stages, or the whole agent. Our central result bounds the gap between observed and controlled score differences using only nuisance outside the window. This yields an admissibility test applied before scores are inspected. Inadmissible comparisons are refused. For admissible pairs, an ordering is certified only when the score gap exceeds the combined sampling and nuisance radii; otherwise, it remains undecided. These decisions give each system a rank interval. We introduce BioLitBench, a benchmark of 2,042 biomedical articles represented as structured claim graphs. Among seven published pipelines, a conventional statistical analysis declares a winner in 14 of 21 pairwise comparisons. Yet the top-ranked system alone received the target review's bibliography. To isolate pipeline performance, our test requires matched inputs and a fixed backbone model. It refuses 11 of the 21 comparisons, including every comparison involving the top-ranked system. Seven of the 14 conventional conclusions fall within these refused pairs. The same comparison windows support stage-level training. We train SCRIBE on Qwen3.8-27B using rewards measured at each stage's exit. Under matched evidence, SCRIBE achieves a certified rank interval of [1,2], with certified advantages over all evaluated published pipelines and the evaluated Claude and OpenAI agents. Under same pool, SCRIBE matches the strongest published retriever and is certified above three published pipelines.

0.35